Featured News
More News
Antibody developed by Dr. Weissman and his colleagues shows promise in a small clinical trial as a safe cancer therapy
An immunotherapy conceived at Stanford appeared safe in an early clinical trial. Half of the participants responded positively to the treatment, aimed at triggering macrophages to engulf cancer cells, the researchers reported.
The ISPAD Clinical Practice consensus Guidelines 2018 are now available online
ISPAD’s Clinical Practice Consensus Guidelines are the only comprehensive set of clinical recommendations for children, adolescents, and young adults with diabetes worldwide!
Bruce Buckingham has won the ISPAD Prize for Innovation in Pediatric Diabetes Care for 2018
Dr. Buckingham is a Professor in the Department of Pediatric Endocrinology at Stanford Medical Center and Stanford Children’s Hospital.
Stanford GSB study identifies most effective way to steer schoolchildren away from sodas and other sweetened drinks toward drinking water instead.
What’s the best way to persuade children to drink water instead of unhealthy, sugar-laced beverages?
Karl Deisseroth receives Transformative Research Award
The Stanford scientists will receive $32 million over five years to fund explorations of cancer, the brain, the aging process, chromosomes and the development of cells.
Following events at the ADA Scientific Sessions in June, a number of concerns raised regarding the ADA's professional section remain unresolved. As a result, a boycott of ADA activities has been initiated by leading figures in diabetes research. The text below includes relevant hyperlinks with further information. Those who wish to review the petition and consider whether to sign it may do so at the links provided. This information is being shared for member awareness.